1. Home
  2. SABA vs TKNO Comparison

SABA vs TKNO Comparison

Compare SABA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABA
  • TKNO
  • Stock Information
  • Founded
  • SABA 1988
  • TKNO 1996
  • Country
  • SABA United States
  • TKNO United States
  • Employees
  • SABA N/A
  • TKNO N/A
  • Industry
  • SABA
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • SABA
  • TKNO Health Care
  • Exchange
  • SABA Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • SABA 257.3M
  • TKNO 256.9M
  • IPO Year
  • SABA N/A
  • TKNO 2021
  • Fundamental
  • Price
  • SABA $9.18
  • TKNO $4.23
  • Analyst Decision
  • SABA
  • TKNO
  • Analyst Count
  • SABA 0
  • TKNO 0
  • Target Price
  • SABA N/A
  • TKNO N/A
  • AVG Volume (30 Days)
  • SABA 290.0K
  • TKNO 224.0K
  • Earning Date
  • SABA 01-01-0001
  • TKNO 08-07-2025
  • Dividend Yield
  • SABA 12.91%
  • TKNO N/A
  • EPS Growth
  • SABA N/A
  • TKNO N/A
  • EPS
  • SABA N/A
  • TKNO N/A
  • Revenue
  • SABA N/A
  • TKNO $38,923,000.00
  • Revenue This Year
  • SABA N/A
  • TKNO $9.52
  • Revenue Next Year
  • SABA N/A
  • TKNO $15.20
  • P/E Ratio
  • SABA N/A
  • TKNO N/A
  • Revenue Growth
  • SABA N/A
  • TKNO 11.40
  • 52 Week Low
  • SABA $3.64
  • TKNO $4.00
  • 52 Week High
  • SABA $4.42
  • TKNO $10.37
  • Technical
  • Relative Strength Index (RSI)
  • SABA 44.32
  • TKNO 40.65
  • Support Level
  • SABA $9.12
  • TKNO $4.22
  • Resistance Level
  • SABA $9.34
  • TKNO $4.94
  • Average True Range (ATR)
  • SABA 0.10
  • TKNO 0.28
  • MACD
  • SABA -0.01
  • TKNO -0.01
  • Stochastic Oscillator
  • SABA 21.15
  • TKNO 13.95

About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest

Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: